Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion

被引:163
|
作者
Kim, Steven C. [1 ]
Mathews, David V. [1 ]
Breeden, Cynthia P. [1 ]
Higginbotham, Laura B. [1 ]
Ladowski, Joseph [2 ]
Martens, Gregory [2 ]
Stephenson, Allison [1 ]
Farris, Alton B. [1 ]
Strobert, Elizabeth A. [3 ]
Jenkins, Joe [3 ]
Walters, Eric M. [2 ]
Larsen, Christian P. [1 ,3 ]
Tector, Matthew [4 ]
Tector, Alfred J. [4 ]
Adams, Andrew B. [1 ,3 ]
机构
[1] Emory Univ, Sch Med, Dept Surg, Emory Transplant Ctr, Atlanta, GA 30322 USA
[2] Univ Missouri, Natl Swine Resource & Res Ctr, Columbia, MO USA
[3] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA
[4] Univ Alabama Birmingham, Sch Med, Comprehens Transplant Inst, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
animal models; nonhuman primate; basic (laboratory) research; science; costimulation; immunosuppressant - fusion proteins and monoclonal antibodies; costimulation molecule specific; immunosuppression; immune modulation; kidney transplantation; nephrology; translational research; xenoantibody; xenoantigen; xenotransplantation; COMPLEMENT REGULATORY PROTEINS; ANTI-CD40 LIGAND ANTIBODY; COSTIMULATION BLOCKADE; GRAFT-REJECTION; ORGAN; TRANSPLANTATION; KNOCKOUT; BABOON; XENOTRANSPLANTATION; SPECIFICITY;
D O I
10.1111/ajt.15329
中图分类号
R61 [外科手术学];
学科分类号
摘要
The shortage of available organs remains the greatest barrier to expanding access to transplant. Despite advances in genetic editing and immunosuppression, survival in experimental models of kidney xenotransplant has generally been limited to <100 days. We found that pretransplant selection of recipients with low titers of anti-pig antibodies significantly improved survival in a pig-to-rhesus macaque kidney transplant model (6 days vs median survival time 235 days). Immunosuppression included transient pan-T cell depletion and an anti-CD154-based maintenance regimen. Selective depletion of CD4(+) T cells but not CD8(+) T cells resulted in long-term survival (median survival time >400 days vs 6 days). These studies suggested that CD4(+) T cells may have a more prominent role in xenograft rejection compared with CD8(+) T cells. Although animals that received selective depletion of CD8(+) T cells showed signs of early cellular rejection (marked CD4(+) infiltrates), animals receiving selective CD4(+) depletion exhibited normal biopsy results until late, when signs of chronic antibody rejection were present. In vitro study results suggested that rhesus CD4(+) T cells required the presence of SLA class II to mount an effective proliferative response. The combination of low pretransplant anti-pig antibody and CD4 depletion resulted in consistent, long-term xenograft survival.
引用
收藏
页码:2174 / 2185
页数:12
相关论文
共 50 条
  • [31] Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, interferon-γ, and CTLA4
    Markees, TG
    Phillips, NE
    Gordon, EJ
    Noelle, RJ
    Shultz, LD
    Mordes, JP
    Greiner, DL
    Rossini, AA
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) : 2446 - 2455
  • [32] LONG-TERM SURVIVAL WITHOUT CLINICAL AIDS AFTER CD4+ CELL COUNTS FALL BELOW 200X10(6)/I
    HOOVER, DR
    RINALDO, C
    HE, YH
    PHAIR, J
    FAHEY, J
    GRAHAM, NMH
    AIDS, 1995, 9 (02) : 145 - 152
  • [33] Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4+Foxp3+ Treg cell accumulation
    Zhang, Zhu-Xu
    Lian, Dameng
    Huang, Xuyan
    Wang, Shuang
    Sun, Hongtao
    Liu, Weihua
    Garcia, Bertha
    Min, Wei-Ping
    Jevnikar, Anthony M.
    TRANSPLANT IMMUNOLOGY, 2011, 24 (02) : 119 - 126
  • [34] Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimen
    Unger, Lukas W.
    Muckenhuber, Moritz
    Mahr, Benedikt
    Schwarz, Christoph
    Pilat, Nina
    Granofszky, Nicolas
    Regele, Heinz
    Wekerle, Thomas
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function
    Giaretta, Fulvia
    Bussolino, Stefania
    Beltramo, Silvia
    Fop, Fabrizio
    Rossetti, Maura
    Messina, Maria
    Cantaluppi, Vincenzo
    Ranghino, Andrea
    Basso, Elisa
    Camussi, Giovanni
    Segoloni, Giuseppe Paolo
    Biancone, Luigi
    TRANSPLANT IMMUNOLOGY, 2013, 28 (01) : 48 - 56
  • [36] Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma
    Chen, Haizhu
    Qin, Yan
    Yang, Jianliang
    Liu, Peng
    Zhang, Changgong
    He, Xiaohui
    Zhou, Shengyu
    Yang, Sheng
    Gui, Lin
    Zhou, Liqiang
    Sun, Yan
    Shi, Yuankai
    ANNALS OF HEMATOLOGY, 2020, 99 (12) : 2847 - 2857
  • [37] Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy
    Voorhees, Timothy J.
    Ghosh, Nilanjan
    Grover, Natalie
    Block, Jared
    Cheng, Catherine
    Morrison, Kaitlin
    Ivanova, Anastasia
    Dotti, Gianpietro
    Serody, Jonathan
    Savoldo, Barbara
    Beaven, Anne W.
    BLOOD ADVANCES, 2020, 4 (23) : 5925 - 5928
  • [38] Regulatory T-cell Number in Peripheral Blood at 1 Year Posttransplant as Predictor of Long-term Kidney Graft Survival
    San Segundo, David
    Galvan-Espinoza, Luis H.
    Rodrigo, Emilio
    Irure, Juan
    Ruiz, Juan C.
    Fernandez-Fresnedo, Gema
    Riesco, Laura
    Bada, Jairo
    Belmar, Lara
    Lopez-Hoyos, Marcos
    TRANSPLANTATION DIRECT, 2019, 5 (03):
  • [39] Kidney transplant patients with long-term graft survival have altered expression of molecules associated with T-cell activation
    Alvarez, CM
    Paris, SC
    Arango, L
    Arbelaez, M
    Garcia, LF
    TRANSPLANTATION, 2004, 78 (10) : 1541 - 1547
  • [40] Variation of CD4+ CD25+ Foxp3+ Regulatory T Cells and Th17 Cells in the Peripheral Blood of Human Liver Allograft Patients With Long-term Survival
    Shi, G.
    Zeng, Q.
    Zhao, Z.
    Li, W.
    Dou, J.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1834 - 1840